Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute changes in thyroid function tests following ingestion of thyroxine.

R G Symons, L J Murphy

    Clinical Endocrinology
    |October 1, 1983
    PubMed
    Summary

    Blood collection timing matters for patients on thyroxine medication. Serum thyroid hormone levels, including total thyroxine (T4), free thyroxine index (FTI), and free T4 (FT4), significantly increase after oral thyroxine intake.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Brain growth trajectories in mouse strains with central and peripheral serotonin differences: relevance to autism models.

    Neuroscience·2012
    Same author

    Longitudinal outcomes after endovascular repair of abdominal aortic aneurysms.

    Vascular and endovascular surgery·2008
    Same author

    Angiogenic factors are elevated in overweight and obese individuals.

    International journal of obesity (2005)·2005
    Same author

    Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo.

    The British journal of dermatology·2005
    Same author

    Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects.

    Diabetic medicine : a journal of the British Diabetic Association·2004
    Same author

    Serum resistin (FIZZ3) protein is increased in obese humans.

    The Journal of clinical endocrinology and metabolism·2004

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Clinical Chemistry

    Background:

    • Thyroxine replacement therapy is common for hypothyroidism.
    • Current guidelines suggest sample timing is inconsequential for monitoring.
    • Variability in serum hormone levels may impact treatment assessment.

    Purpose of the Study:

    • To investigate the impact of oral thyroxine ingestion timing on serum thyroid hormone levels.
    • To determine if current practices for blood sample collection are adequate for assessing patients on thyroxine.
    • To establish optimal timing for blood collection in patients receiving thyroxine therapy.

    Main Methods:

    • Administered therapeutic doses of thyroxine (100-300 micrograms) to euthyroid subjects and patients on replacement therapy.

    Related Experiment Videos

  • Collected blood samples at various time points before and after thyroxine ingestion.
  • Measured serum concentrations of total thyroxine (T4), free thyroxine index (FTI), free T4 (FT4), and other thyroid hormones.

    • Main Results:

    • Significant increases in T4, FTI, and FT4 were observed post-ingestion across all doses.
    • Elevated levels of T4, FTI, and FT4 persisted for at least 6 hours.
    • Supranormal levels were only noted after the highest thyroxine dose.
    • No significant changes were found in triiodothyronine or thyrotropin levels.

    Conclusions:

    • The timing of blood sample collection relative to thyroxine ingestion significantly affects T4, FTI, and FT4 levels.
    • Results suggest that current assessment protocols may need revision.
    • Standardizing blood collection times is crucial for accurate interpretation of thyroid hormone levels in patients on thyroxine replacement.